&Partners’s Vivani Medical, Inc. Warrants expiring 03/14/2024 VANIW Stock Holding History

&Partners’s Portfolio VANIW Stock Details VANIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,745	Closed	-$4K	–	169
2019 Q3	$4K	Hold	2,745	–	–	0.01%	157
2019 Q2	$5K	Hold	2,745	–	–	0.01%	151
2019 Q1	$4K	Buy	+2,745	New	+$5.08K	0.01%	147

Other funds holding VANIW

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

&Partners's VANIW Position: Q4 2019 in Review

&Partners sold out of Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) in Q4 2019, closing a stake of 2,745 shares — an estimated $4K sold.

&Partners first reported a position in VANIW in Q1 2019 and held it in 3 quarters. The position peaked at $5K in Q2 2019. 8 funds tracked by Wall St. Rank hold VANIW as of Q4 2019.

&Partners reported no remaining Vivani Medical, Inc. Warrants expiring 03/14/2024 position as of Q4 2019 after selling out during the quarter.
&Partners sold 2,745 Vivani Medical, Inc. Warrants expiring 03/14/2024 shares in Q4 2019, an estimated $4K.
&Partners first reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 in Q1 2019 and held it in 3 quarters.
&Partners's Vivani Medical, Inc. Warrants expiring 03/14/2024 position peaked at $5K in Q2 2019.
8 funds tracked by Wall St. Rank held Vivani Medical, Inc. Warrants expiring 03/14/2024 as of Q4 2019.

Based on &Partners's 13F filing for Q4 2019, filed 10 Jan 2020.